View the slide viewer

Have questions about this assay kit?

Zebrafish RARa isoform A Reporter Assay Kit

SIZE SKU PRICE
1 x-96 well format assays
3 x-32 assays in-96 well format
SIZE SKU
1 x-96 well format assays
3 x-32 assays in-96 well format

Product Description and Product Data

This is an all-inclusive cell-based luciferase reporter assay kit targeting the Zebrafish Retinoic Acid Receptor alpha isoform A. INDIGO’s zRAR alpha reporter assay utilizes proprietary non-human cells that have been engineered to provide constitutive expression of the zRAR alpha. In addition to zRAR alpha Reporter Cells, this kit provides two optimized media for use during cell culture and in diluting the user’s test samples, a reference agonist, Luciferase Detection Reagent, and a cell culture-ready assay plate. The principal application of this assay is in the screening of test samples to quantify any functional activity, either agonist or antagonist, that they may exert against zRAR alpha. This kit provides researchers with clear, reproducible results, exceptional cell viability post-thaw, and consistent results lot to lot. Kits must be stored at -80C. Do not store in liquid nitrogen. Note: reporter cells cannot be refrozen or maintained in extended culture.

Features

  • Clear, Reproducible Results

  • All-Inclusive Assay Systems
  • Exceptional Cell Viability Post-Thaw
  • Consistent Results Lot to Lot

Product Specifications

Target TypeNuclear Hormone Receptor, Nuclear Receptor Orthologs
SpeciesZebrafish
Receptor FormHybrid
Assay ModeAgonist, Antagonist
Kit Components
  • Zebrafish RARa isoform A Reporter Cells
  • Cell Recovery Medium (CRM)
  • Compound Screening Medium (CSM)
  • 9-cis Retinoic Acid, (ref. agonist; in DMSO)
  • Detection Substrate
  • Detection Buffer
  • White, sterile, cell-culture ready assay plate
Shelf Life6 months
Shipping RequirementsDry Ice
Storage temperature-80C

Data

Reference agonists 9-cis-Retinoic Acid (9-cis-RA; provided), all transRetinoic Acid (ATRA), AM 80, AM 580, and Adapalene (all from Tocris); n ≥ 3 / treatment. APPENDIX 1 describes a 7-point dilution scheme for the provided reference agonist 9-cis-RA.
Assay wells were co-treated with a fixed EC80 concentration of the agonist 9-cis-RA and varying concentrations of the individual antagonists ER 50891, BMS 195614 (Tocris) and Ro 41-5253 (Enzo). Luminescence was quantified and average Relative Light Units (RLU) and their respective values of standard deviation (SD), coefficient of variation (CV), and signal-tobackground (S/B) were determined for each treatment concentration. Z’ values were calculated as described by Zhang, et al. (1999). Non-linear regression analyses were performed and EC50 / IC50 values determined using GraphPad Prism software.

Target Background

Retinoic acid receptors (RARs) are nuclear hormone receptors of the NRB1 class, which function as heterodimers with retinoid X receptors (RXRs). There are three distinct RAR subtypes: RARalpha, RARbeta, and RARgamma. RARalpha is present in most tissue types, whereas RARbeta and RARgamma expression is more selective. RXR-RAR heterodimers act as ligand-dependent transcriptional regulators by binding to the specific retinoic acid response element (RARE) found in the promoter regions of target genes. In the absence of an RAR agonist, RXR-RAR recruits co-repressor proteins such as NCoR and associated factors such as histone deacetylase to maintain a condensed chromatin structure. RAR agonist binding stimulates co-repressor release and co-activator complexes, such as histone acetyltransferase, are recruited to activate transcription. RARs transduce retinoid signals in vivo, which mediates proper embryogenesis, differentiation and growth arrest. Specifically, RXRalpha-RARgamma heterodimers are necessary for growth arrest and viseral and primitive endodermal differentiation, whereas RXRalpha-RARalpha is required for cAMP-dependent parietal endodermal differentiation. In vitro it has been difficult to elucidate the roles of individual subtypes as functional RAR knockouts generate artificial redundancies that are thought not to exist under normal conditions.

INDIGO’s Zebrafish Retinoic Acid Receptor, Alpha A (zRARαa) Reporter Assay System utilizes proprietary non-human cells engineered to provide constitutive, high-level expression of Zebrafish (Danio rerio) RARαa (NR1B1 isoform A), a ligand-dependent transcription factor.

INDIGO’s Reporter Cells express a hybrid zebrafish RARαa receptor in which the native N-terminal ligand binding domain (LBD) has been substituted with that of the yeast GAL4 LBD sequence. Accordingly the resident luciferase reporter gene is functionally linked to tandem copies of the Gal4 upstream activation sequence. Thus, quantifying changes in luciferase expression in the treated reporter cells provides a sensitive surrogate measure of changes in zRARαa. The principal application of this assay is in the screening of test samples to quantify any functional bioactivity that they may exert against zebrafish RARαa. In particular, zebrafish reporter assays are frequently used in the monitoring of environmental samples for the presence of biohazardous chemical pollutants, such as endocrine disruptors.

Also available as a service

Retinoic Acid Receptor Alpha (RARa, NR1B1)

Have questions about this assay kit?